查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387290

症状多重诊断市场报告：2030 年趋势、预测与竞争分析

Syndromic Multiplex Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

症状多重诊断的趋势和预测

到 2030 年，全球症状多重诊断市场预计将达到 42.5 亿美元，2024 年至 2030 年复合年增长率为 7.5%。该市场的主要驱动因素是感染疾病的日益普及、分子诊断技术的日益采用以及对准确、快速结果和快速获得治疗的需求不断增长。全球症状多重诊断市场的未来充满希望，医院和诊断实验室市场存在商机。

症状多重诊断市场洞察

Lucintel 预测，在预测期内，消化器官系统系统将继续占据更大的份额，因为它有助于识别引起胃肠炎和食物中毒等疾病的病原体。

在这个市场中，由于医院进行了大量的诊断测试，预计医院仍将是最大的细分市场。

由于医疗保健支出不断增加，对早期准确诊断的需求不断增加，以及各种传染性和非传染性疾病的盛行率不断增加，北美在预测期内可能仍然是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 哪个产业将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球症状多重诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球症状多重诊断市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球症状多重诊断市场
    • 呼吸系统
    • 消化器官系统
    • 中枢神经系统
    • 其他的
  • 按最终用途分類的全球症状多重诊断市场
    • 医院
    • 诊断实验室
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球症状多重诊断市场
  • 北美症状多重诊断市场
  • 欧洲症状多重诊断市场
  • 亚太地区症状多重诊断市场
  • 其他地区症状多重诊断市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球症状多重诊断市场成长机会
    • 按最终用途分類的全球症状多重诊断市场的成长机会
    • 按地区分類的全球症状多重诊断市场成长机会
  • 全球症状多重诊断市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球症状多重诊断市场的产能扩张
    • 全球症状多重诊断市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • BioMerieux
  • Qiagen
  • DiaSorin SpA
  • Applied BioCode
  • Akonni Biosystems
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Accelerate Diagnostic
  • Becton and Dickinson
  • Hologic
简介目录

Syndromic Multiplex Diagnostic Trends and Forecast

The future of the global syndromic multiplex diagnostic market looks promising with opportunities in the hospitals and diagnostics laboratories markets. The global syndromic multiplex diagnostic market is expected to reach an estimated $4.25 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are increasing prevalence of infectious disease, rising adoption of molecular diagnostic techniques, and growing demand for accurate and rapid results and quick access to the treatment.

A more than 150-page report is developed to help in your business decisions.

Syndromic Multiplex Diagnostic by Segment

The study includes a forecast for the global syndromic multiplex diagnostic by type, end use, and region.

Syndromic Multiplex Diagnostic Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Respiratory
  • Gastrointestinal
  • Central Nervous System
  • Others

Syndromic Multiplex Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostics Laboratories
  • Others

Syndromic Multiplex Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Syndromic Multiplex Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies syndromic multiplex diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the syndromic multiplex diagnostic companies profiled in this report include-

  • Biomerieux
  • Qiagen
  • Diasorin S.P.A
  • Applied Biocode
  • Akonni Biosystems
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Accelerate Diagnostic
  • Becton and Dickinson
  • Hologic

Syndromic Multiplex Diagnostic Market Insights

Lucintel forecasts that gastrointestinal will remain the larger segment over the forecast period as it helps in identifing pathogens responsible for diseases like gastroenteritis and foodborne illnesses.

Within this market, hospitals is expected to remain the largest segment due to the high volume of diagnostic tests performed in hospitals.

North America will remain the largest region during the forecast period due to rising healthcare expenditure, growing demand for early and accurate diagnosis, and increasing prevalence of various communicable or non-communicable diseases.

Features of the Global Syndromic Multiplex Diagnostic Market

Market Size Estimates: Syndromic multiplex diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Syndromic multiplex diagnostic market size by type, end use, and region in terms of value ($B).

Regional Analysis: Syndromic multiplex diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the syndromic multiplex diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the syndromic multiplex diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the syndromic multiplex diagnostic market size?

Answer: The global syndromic multiplex diagnostic market is expected to reach an estimated $4.25 billion by 2030.

Q2. What is the growth forecast for syndromic multiplex diagnostic market?

Answer: The global syndromic multiplex diagnostic market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the syndromic multiplex diagnostic market?

Answer: The major drivers for this market are increasing prevalence of infectious disease, rising adoption of molecular diagnostic techniques, and growing demand for accurate and rapid results and quick access to the treatment.

Q4. What are the major segments for syndromic multiplex diagnostic market?

Answer: The future of the syndromic multiplex diagnostic market looks promising with opportunities in the hospitals and diagnostics laboratories markets.

Q5. Who are the key syndromic multiplex diagnostic market companies?

Answer: Some of the key syndromic multiplex diagnostic companies are as follows:

  • Biomerieux
  • Qiagen
  • Diasorin S.P.A
  • Applied Biocode
  • Akonni Biosystems
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Accelerate Diagnostic
  • Becton and Dickinson
  • Hologic

Q6. Which syndromic multiplex diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that gastrointestinal will remain the larger segment over the forecast period as it helps in identifing pathogens responsible for diseases like gastroenteritis and foodborne illnesses.

Q7. In syndromic multiplex diagnostic market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest region during the forecast period due to rising healthcare expenditure, growing demand for early and accurate diagnosis, and increasing prevalence of various communicable or non-communicable diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the syndromic multiplex diagnostic market by type (respiratory, gastrointestinal, central nervous system, and others), end use (hospitals, diagnostics laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Syndromic Multiplex Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Syndromic Multiplex Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Syndromic Multiplex Diagnostic Market by Type
    • 3.3.1: Respiratory
    • 3.3.2: Gastrointestinal
    • 3.3.3: Central Nervous System
    • 3.3.4: Others
  • 3.4: Global Syndromic Multiplex Diagnostic Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Diagnostics Laboratories
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Syndromic Multiplex Diagnostic Market by Region
  • 4.2: North American Syndromic Multiplex Diagnostic Market
    • 4.2.2: North American Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others
  • 4.3: European Syndromic Multiplex Diagnostic Market
    • 4.3.1: European Syndromic Multiplex Diagnostic Market by Type: Respiratory, Gastrointestinal, Central Nervous System, and Others
    • 4.3.2: European Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others
  • 4.4: APAC Syndromic Multiplex Diagnostic Market
    • 4.4.1: APAC Syndromic Multiplex Diagnostic Market by Type: Respiratory, Gastrointestinal, Central Nervous System, and Others
    • 4.4.2: APAC Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others
  • 4.5: ROW Syndromic Multiplex Diagnostic Market
    • 4.5.1: ROW Syndromic Multiplex Diagnostic Market by Type: Respiratory, Gastrointestinal, Central Nervous System, and Others
    • 4.5.2: ROW Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Syndromic Multiplex Diagnostic Market by Type
    • 6.1.2: Growth Opportunities for the Global Syndromic Multiplex Diagnostic Market by End Use
    • 6.1.3: Growth Opportunities for the Global Syndromic Multiplex Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Syndromic Multiplex Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Syndromic Multiplex Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Syndromic Multiplex Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: BioMerieux
  • 7.2: Qiagen
  • 7.3: DiaSorin S.p.A
  • 7.4: Applied BioCode
  • 7.5: Akonni Biosystems
  • 7.6: Thermo Fisher Scientific
  • 7.7: Abbott Laboratories
  • 7.8: Accelerate Diagnostic
  • 7.9: Becton and Dickinson
  • 7.10: Hologic